Log in Subscribe

Biometric Testing Firm Adding New HQ

Posted

PTS Diagnostics, a U.S.–based manufacturer of point-of-care biometric testing devices, announced that they are expanding operations in Indianapolis and building a new $30 million global headquarters.

In order to support continued rapid growth, the in vitro diagnostics company is investing in additional manufacturing and office space, and moving their global headquarters to Whitestown. The new 135,000 square foot building is slated to open in June of 2019 on the southwest corner of Anson Blvd and C.R. 450 South.

A private groundbreaking ceremony with executives, architects, builders and representatives from PTS Diagnostics’ parent company, Sinocare, was recently held. A company-wide celebration is planned for summer 2018.

“PTS Diagnostics is still in high-growth mode, and our organization has evolved considerably in the past decade,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “As an organization, we pride ourselves on the ability to adhere to our core Hoosier values while scaling the business globally in accordance with growing demand and the expansion of our product lines. In addition to acquiring a manufacturing facility in California, we recently opened a sales office in Bangalore, India. In December, we announced the launch of a new retail point-of-care software for health screeners that is poised to create a niche in the expanding field of population health management.”

PTS Diagnostics currently has more than 150 employees in its flagship Indianapolis location and 86 employees in its Sunnyvale, California facility, which was acquired in late 2013. The company continues to grow much faster than the rate of industry growth, and this expansion will bring jobs to Indianapolis in the finance, marketing, chemistry, engineering, and manufacturing sectors, amongst others.

According to Indiana University’s Kelley School of Business, the economic impact of Indiana’s life sciences industry has climbed to more than $63 billion and is comprised of roughly 60,000 employees – making it one of the top states for in vitro diagnostics.

“The Browning/Duke Realty joint venture is proud to partner with PTS Diagnostics and assist them with the development of a building that is capable of meeting their growth and manufacturing needs, said Mark Hosfeld, Vice President of Leasing and Development at Duke Realty. “Indiana has a booming life sciences sector and this new global headquarters represents a continued commitment to the point-of-care technology that will further solidify their place in this rapidly growing industry.”